| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Amicus Therapeutics, Inc. (FOLD) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 10 sells. FOLD is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.02M | $14.80M | - | |
| Other | 464.6K | $6.73M | - | |
| Other | 409.3K | $5.93M | - | |
| Other | 221.8K | $3.21M | - | |
| CFO | 143.6K | $2.08M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 1, 2020 | Crowley John F67 | Chairman &CEO | Sell | 9,755 | $11.32 | $110,468.55 | -1.0% | |
| Apr 17, 2020 | McGlynn Margaret G51 | Director | Sale+OE | 10,000 | $11.00 | $110,000.00 | -31.2% | |
| Apr 15, 2020 | Crowley John F67 | Chairman &CEO | Sale+OE | 20,000 | $9.92 | $198,412.00 | -2.1% | |
| Apr 7, 2020 | Campbell Bradley L66 | Chief Operating Officer | Sale+OE | 2,500 | $10.12 | $25,300.00 | -0.7% | |
| Apr 1, 2020 | Crowley John F67 | Chairman &CEO | Sell | 9,755 | $9.08 | $88,607.59 | -1.1% | |
| Apr 1, 2020 | Campbell Bradley L66 | Chief Operating Officer | Sale+OE | 15,003 | $9.09 | $136,309.76 | -4.1% | |
| Mar 20, 2020 | Crowley John F67 | Chairman &CEO | Sale+OE | 20,000 | $9.00 | $180,000.00 | -2.1% | |
| Mar 5, 2020 | Campbell Bradley L66 | Chief Operating Officer | Sale+OE | 2,500 | $10.01 | $25,025.00 | -0.7% | |
| Mar 2, 2020 | Crowley John F67 | Chairman &CEO | Sell | 9,755 | $9.10 | $88,745.14 | -1.1% | |
| Mar 2, 2020 | Campbell Bradley L66 | Chief Operating Officer | Sale+OE | 15,003 | $9.09 | $136,444.78 | -4.0% |